SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is rallying as investors react to a strategic $14.2 billion deal to regain full ownership of its Ireland-based Fab 34, a move perceived as a major vote of confidence in the company's manufacturing and AI-driven growth trajectory. The community is actively debating the stock's future, with many interpreting the heavy capital reinvestment as a clear indicator that major new customer contracts are imminent.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is currently trending following news that it has secured FDA approval for VYKAT XR, the first therapy developed to treat hyperphagia in Prader-Willi syndrome. The community is actively discussing the stock's significant price momentum, debating the potential for a future acquisition by a larger pharmaceutical player, and evaluating the long-term commercial execution of this newly approved asset.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as the market reacts to the company's latest subscription price hikes, which analysts view as a strategic move to fund a massive content budget and solidify profitability. While some retail investors are voicing frustration over recurring cost increases, the community is heavily focused on the stock's relative strength and technical breakout potential, with many discussing its role as a hedge against broader market volatility.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

The Next Bitcoin

Investors are rallying behind this Solana-based meme coin as a satirical movement intended to mock established market structures, with community members actively comparing its long-term potential to industry giants. Discussions are currently dominated by enthusiasts promoting the token's cultural narrative and its goal of creating viral engagement within the broader crypto ecosystem.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Neurocrine Biosciences is trending as the market reacts to the definitive agreement to acquire Soleno Therapeutics for $2.9 billion. Community sentiment is mixed, with active debate regarding whether the acquisition effectively addresses Neurocrine's need for pipeline growth or if the premium paid for the rare-disease asset signals a strategic overpay.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is seeing significant investor interest driven by a combination of resilient pricing power in its core smokeable business and ongoing momentum in its smoke-free portfolio, particularly with the growth of its on! nicotine pouches. The community is actively debating the company's long-term pivot from traditional cigarettes toward smoke-free alternatives, with many highlighting the stock's role as a classic, high-yield defensive play in a volatile market.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines is experiencing a significant surge in momentum as the company reports positive trial results for its essential tremor and epilepsy therapies, driving multiple analyst price target upgrades. While the community is debating the impact of a recent large-scale public offering, many investors remain bullish on the long-term potential of the company's CNS-focused pipeline.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as shareholders analyze the strategic implications of parent company Centurium Capitals acquisition of Blue Bottle Coffee. While the community remains divided over potential conflicts of interest versus synergistic growth, investors are closely monitoring for signs of a long-anticipated U.S. exchange relisting and are actively debating the stock's future valuation amid shifting institutional ownership.

A2Z Cust2Mate Solutions Corp. is a technology company, which engages in the development and commercialization of retail smart cart solutions for large grocery stores and supermarkets. It operates through the Smart Carts and Precision Metal Parts segments. The Smart Carts segment offers retail automation solutions. Its platform enables seamless in-cart scanning and payment, allowing shoppers to bypass checkout lines while receiving real-time customized offers and product recommendations. The Precision Metal Parts segment includes the manufacturing and sale of precision metal parts. The company was founded by Joseph Bentsur on January 15, 2018 and is headquartered in Vancouver, Canada.

A2Z Cust2Mate Solutions Corp.

A2Z Smart Technologies Corp.

A2Z Smart Technologies is trending following a major five-year strategic agreement to deploy 4,000 smart shopping carts at Carrefour Israel, a move the community views as a significant model for global scalability. Investors are actively discussing the company's retail media expansion, potential for recurring revenue, and bullish technical setups, with many highlighting institutional interest from significant fund stakes as a vote of confidence in the stock's long-term growth trajectory.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is currently trending due to intense speculation surrounding a potential short squeeze, driven by extremely limited share availability for borrowing and surging borrow fees. The community is actively debating the stock's volatility, with many retail traders drawing comparisons to historical meme stock runs while critics emphasize the company's lack of revenue and potential for dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Sigma Lithium stock surged over 38% and was among the top trending tickers on Stocktwits.</li><li>Atlas Lithium gained 2.9%, Albemarle traded 2.7% higher, Lithium Americas rose 2%, and American Lithium shot up over 7%.</li><li>Lithium carbonate futures in China was trading 1.72% higher at 87,000 yuan per tonne.</li></ul>&nbsp;Lithium stocks came under retail spotlight in Wednesday’s premarket trade after lithium prices rose to 16-month highs.On Wednesday, Lithium carbonate futures in China traded 1.72% higher at 87,000 yuan per tonne ($12,507), their highest level since July 2024.Shares of Sigma Lithium Corp. (SGML) surged over 38% in premarket on Wednesday to their highest level in over seven months. Other lithium stocks were also in the green with Atlas Lithium Corp. (ATLX) up 2.9%, Albemarle Corp (ALB) trading 2.7% higher, Lithium Americas Corp (LAC) gaining 2%, and American Lithium Corp (AMLIF) scaling over 7%.Earlier this week, SGML stock hit its 200-day moving average (200-DMA) mark for the first time since March 2025. The stock recorded a 32% gain on Monday, boosted by its third-quarter (Q3) print. Revenue rose 36% to $28.5 million, while its loss narrowed to $6.2 million from a loss of $11.4 million last year. Total debt declined by 11%.However, the stock has been under selling pressure so far this year, shedding more than 30%.<h2 class="st-heading-2">Why Is Lithium Price Increasing?</h2>Lithium carbonate prices in China have climbed sharply in recent weeks, as investors bet on strong future demand driven by the fast-growing energy storage market amid the rise in the number of AI data centers.On Monday, Bloomberg, citing local outlet Cailian, reported that Ganfeng Lithium Group Co. chairman Li Liangbin expects lithium’s demand to increase by around 30% in 2026. Li reportedly said that if demand growth next year exceeds 30% and approaches 40%, lithium prices could climb sharply, potentially reaching 150,000 yuan or even 200,000 yuan per ton.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for SGML on Stocktwits remained in the ‘extremely bullish’ territory for the past 24 hours, amid ‘extremely high’ message volumes. At the time of writing, SGML was among the top trending tickers on the platform.Sentiment for ATLX stock changed to ‘extremely bullish’ from ‘bullish’ a day earlier, while ALB’s sentiment remained unchanged at ‘bullish’ for the past 24 hours, accompanied by ‘high’ message volumes.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-et-fs-bleed-for-5th-straight-session/cLPo5JuREJq">Bitcoin ETFs Bleed For 5th Straight Session — Sen. Tim Scott Hopes To Send Crypto Bill To Trump’s Desk Early Next Year</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mining trucks load lithium sulfate, in Atacama Salt Flat, Chile.

Why Are Lithium Stocks Gaining In Pre-Market Today?

Lithium carbonate prices have jumped in recent weeks, driven by stronger demand amid the rapid expansion of AI data centers, which is boosting the energy storage sector.

Equity

Is American Lithium (AMLIF) Stock Outpacing Its Basic Materials Peers This Year?

Here is how American Lithium Corp. (AMLIF) and Fury Gold Mines Limited (FURY) have performed compared to their sector so far this year.

All You Need to Know About American Lithium (AMLIF) Rating Upgrade to Buy

American Lithium (AMLIF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

American Lithium Corp. is an exploration stage company. It engages in the acquisition, exploration, and development of lithium deposits. The firm is focused on exploring and developing the TLC Lithium, Falchani Lithium, and Macusani Uranium projects. The company was founded on February 25, 1974 and is headquartered in Vancouver, Canada.

American Lithium Corp

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

AMLIF
American Lithium Corp

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AMLIF News

AMLIFAmerican Lithium Corp